JPS5651447A - Cholecalciferol derivative - Google Patents

Cholecalciferol derivative

Info

Publication number
JPS5651447A
JPS5651447A JP12537280A JP12537280A JPS5651447A JP S5651447 A JPS5651447 A JP S5651447A JP 12537280 A JP12537280 A JP 12537280A JP 12537280 A JP12537280 A JP 12537280A JP S5651447 A JPS5651447 A JP S5651447A
Authority
JP
Japan
Prior art keywords
cholecalciferol derivative
cholecalciferol
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12537280A
Other languages
English (en)
Other versions
JPH0144695B2 (ja
Inventor
Barunaa Rihiaruto
Hiyupushiyaa Yoozefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS5651447A publication Critical patent/JPS5651447A/ja
Publication of JPH0144695B2 publication Critical patent/JPH0144695B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP12537280A 1979-09-14 1980-09-11 Cholecalciferol derivative Granted JPS5651447A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH834679A CH644100A5 (de) 1979-09-14 1979-09-14 Cholecalciferolderivate.

Publications (2)

Publication Number Publication Date
JPS5651447A true JPS5651447A (en) 1981-05-09
JPH0144695B2 JPH0144695B2 (ja) 1989-09-29

Family

ID=4338917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12537280A Granted JPS5651447A (en) 1979-09-14 1980-09-11 Cholecalciferol derivative

Country Status (10)

Country Link
US (1) US4407754A (ja)
JP (1) JPS5651447A (ja)
AT (1) AT372943B (ja)
BE (1) BE885204A (ja)
CH (1) CH644100A5 (ja)
DE (1) DE3034722A1 (ja)
FR (1) FR2468587A1 (ja)
GB (1) GB2060642B (ja)
IT (1) IT1131777B (ja)
NL (1) NL8005064A (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
EP0086350A3 (de) * 1982-02-12 1984-11-28 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholesterinderivaten
ZA83923B (en) * 1982-02-12 1983-11-30 Hoffmann La Roche Use of cholecalciferol derivatives
US5120722A (en) * 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
DE3854089T2 (de) * 1988-07-05 1995-11-02 Kuraray Co Steroid-verbindungen.
CN101381389B (zh) * 2008-09-29 2011-05-25 浙江工业大学 5,7-双烯甾类化合物的化学合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3739001A (en) * 1971-10-22 1973-06-12 Wisconsin Alumni Res Found 25,26-dihydroxycholecalciferol
US4204995A (en) * 1978-03-15 1980-05-27 Hoffmann-La Roche Inc. Cholestane derivatives
EP0019059B1 (de) * 1979-05-18 1982-12-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholestenderivaten und neue Zwischenprodukte in deren Herstellung
US4265822A (en) * 1979-09-10 1981-05-05 Wisconsin Alumni Research Foundation Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds

Also Published As

Publication number Publication date
CH644100A5 (de) 1984-07-13
FR2468587B1 (ja) 1984-10-19
NL8005064A (nl) 1981-03-17
US4407754A (en) 1983-10-04
GB2060642B (en) 1983-11-30
ATA459980A (de) 1983-04-15
DE3034722A1 (de) 1981-04-02
GB2060642A (en) 1981-05-07
IT1131777B (it) 1986-06-25
IT8023753A0 (it) 1980-07-28
FR2468587A1 (fr) 1981-05-08
AT372943B (de) 1983-11-25
BE885204A (fr) 1981-03-12
JPH0144695B2 (ja) 1989-09-29

Similar Documents

Publication Publication Date Title
ZA80838B (en) Self-advance mechanism
JPS55130981A (en) Oxapenem derivative
JPS5690084A (en) Benzimidazolinone derivative
JPS5651456A (en) 22phenyltetraline derivative
JPS55148637A (en) Antiilocking mechanism
JPS55114608A (en) Beaddbreaker mechanism
JPS5625152A (en) 33methyleneazetizine derivative
CS409780A1 (en) Zpusob kontinualniho valcovani i profilu
JPS5651447A (en) Cholecalciferol derivative
JPS55160778A (en) Imidazobenzodiazepine derivative
JPS5651448A (en) 155sulfonamidoprostaglandin derivative
JPS56124000A (en) Steroiddspiroooxazolidinone derivative
JPS5692844A (en) Novel 22aminoethanol derivative
GB2047703B (en) Oxa-lactam derivative
GB2065781B (en) Balanding reciprocoating-piston mechanisms
GB2047707B (en) Oxa-lactam derivative
GB2065099B (en) Taurine derivative
JPS565454A (en) Amidothiol derivative
JPS5610181A (en) 22thioxoo33benzothiazolineacetonitrile derivative
JPS5632455A (en) 33aminopropoxyaryl derivative
GB8304071D0 (en) Cholestenes
JPS5661382A (en) Oxayohimbine derivative
JPS5661348A (en) Propioneamidoxime derivative
JPS5681588A (en) Pyridazopyridazine derivative
JPS55100361A (en) 33aminopropoxyaryl derivative